Edition:
United States

Beijing Leadman Biochemistry Co Ltd (300289.SZ)

300289.SZ on Shenzhen Stock Exchange

15.05CNY
--
Change (% chg)

-- (--)
Prev Close
¥15.05
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
3,807,801
52-wk High
¥17.53
52-wk Low
¥10.31

300289.SZ

Chart for 300289.SZ

About

Beijing Leadman Biochemistry Co., Ltd is a China-based company principally engaged in the research, development, production and sales of in-vitro diagnostic reagents. Its diagnostic reagents include chemiluminescence diagnostic reagents and biochemical diagnostic agents, such as hepatitis B virus attributes and tumor markers.... (more)
No analyst recommendations are available for 300289.SZ.

Overall

Beta: 0.97
Market Cap(Mil.): ¥6,378.27
Shares Outstanding(Mil.): 423.81
Dividend: 0.01
Yield (%): 0.40

Financials

  300289.SZ Industry Sector
P/E (TTM): 93.24 79.21 32.38
EPS (TTM): 0.16 -- --
ROI: 6.63 3.63 14.90
ROE: 5.54 5.49 16.15

BRIEF-Beijing Leadman Biochemistry signs cooperation contract

* Says it signs cooperation contract for study on the suitability in Vitros5600

Jul 17 2017

BRIEF-Beijing Leadman Biochemistry says dividend payment date

* Says it pay a cash dividend of 0.1 yuan per 10 shares (before tax) for 2016 to shareholders of record on June 14

Jun 08 2017

BRIEF-Beijing Leadman Biochemistry receives patent

* Says it received patent(No. ZL 2013 1 0522632.X), for level detecting and sensing devices used on fully automatic biochemistry analyzer

May 12 2017

BRIEF-Beijing Leadman Biochemistry to pay cash div 0.1 yuan per 10 shares for FY 2016

* Says it plans to pay cash div 0.1 yuan per 10 shares for FY 2016

Apr 25 2017

BRIEF-Beijing Leadman Biochemistry Co Ltd sees Q1 FY 2017 net profit down 10 pct to up 10 pct

* Sees Q1 FY 2017 net profit to decrease by 10 percent to increase by 10 percent, or to be 16.2 million yuan to 19.8 million yuan

Apr 10 2017

Earnings vs. Estimates